Method for preventing or treating osteoporosis, characterized by administering teriparatide or salt thereof at a frequency of twice a week

Abstract

[Problems] To provide a method for treating and/or preventing osteoporosis with teriparatide or a salt thereof, the method having excellent safety and/or efficacies. [Solving Means] A method for treating and/or preventing osteoporosis in which teriparatide or a salt thereof is an active ingredient, including administering teriparatide or a salt thereof in a unit dose of 28.2 μg at a frequency of twice a week.

1 . An osteoporosis therapeutic and/or prophylactic agent comprising teriparatide or a salt thereof as an active ingredient, characterized in that the teriparatide or a salt thereof is administered m a unit dose of 28.2 μg at a frequency of mice a week. 
     
     
         2 . The osteoporosis therapeutic and/or prophylactic agent according to  claim 1 , wherein the intervals (not including the days of administration) of administration of twice a week are a 2-day interval and a 3-day interval. 
     
     
         3 . The osteoporosis therapeutic and/or prophylactic agent according to  claim 1 , wherein when the number of weeks of a period administered at a frequency of twice a week is defined as n, and the number of weeks in which the intervals (not including the days of administration) of administration of twice a week out of the n weeks are a 2-day interval and a 3-day interval is defined as m, (m/n)×100(%) is 70% or more. 
     
     
         4 . The osteoporosis therapeutic and/or prophylactic agent according to  claim 1 , which is subcutaneously administered. 
     
     
         5 . The osteoporosis therapeutic and/or prophylactic agent according to  claim 2 , which is subcutaneously administered. 
     
     
         6 . The osteoporosis therapeutic and/or prophylactic agent according to  claim 3 , which is subcutaneously administered.